Clinical Trial Update: Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous fosfomycin for prosthetic joint infection to assess efficacy and safety; sponsor listed as Pro-Implant Foundation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection

Drugs mentioned

• Fosfomycin (intravenous) (fosfomycin)

Snippet

Sponsor: Pro-Implant Foundation | Conditions: Prosthetic Joint Infection | Phase 4 | Status: UNKNOWN